RSV vaccine manufacturers vie for market share in second year of vaccinations
Pfizer, GSK and Moderna’s competition to supply new respiratory syncytial virus (RSV) vaccines is on Wall Street’s watch list as the companies will report their earnings later this week.
ENTRADAS POPULARES
Poland prepares for peaking floods
septiembre 20, 2024
Italy evacuates thousands as Boris hits the north
septiembre 20, 2024
China and the US race to tame nuclear fusion for clean energy
septiembre 20, 2024
TRANSMISIÓN EN VIVO